[Are oral contrast media required for follow-up assessments?].
Diederich
S
S
Institut für Diagnostische und Interventionelle Radiologie/Nuklearmedizin, Marien-Hospital, Rochusstr. 2, 40479, Düsseldorf, Deutschland. s.diederich@marien-hospital.de
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001466:Barium Sulfate / Q000008:administration & dosage / Q000009:adverse effects; D003287:Contrast Media / Q000008:administration & dosage* / Q000009:adverse effects; D004067:Digestive System Neoplasms / Q000000981:diagnostic imaging*; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D007479:Iopamidol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D017060:Patient Satisfaction; D010534:Peritoneal Neoplasms / Q000000981:diagnostic imaging*; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D036542:Tomography, Spiral Computed / Q000379:methods*; D014565:Urogenital Neoplasms / Q000000981:diagnostic imaging*; D055815:Young Adult
D003287:Contrast Media; C057937:iomeprol; D001466:Barium Sulfate; D007479:Iopamidol